| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | tacedinaline | CTRPv2 | pan-cancer | AAC | -0.11 | 0.005 |
| mRNA | BI-2536 | CTRPv2 | pan-cancer | AAC | -0.09 | 0.006 |
| mRNA | Ko-143 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.007 |
| mRNA | PX-12 | CTRPv2 | pan-cancer | AAC | -0.078 | 0.008 |
| mRNA | procarbazine | CTRPv2 | pan-cancer | AAC | -0.11 | 0.008 |
| mRNA | PL-DI | CTRPv2 | pan-cancer | AAC | -0.086 | 0.008 |
| mRNA | rigosertib | CTRPv2 | pan-cancer | AAC | -0.09 | 0.009 |
| mRNA | ceranib-2 | CTRPv2 | pan-cancer | AAC | -0.089 | 0.009 |
| mRNA | BMS-536924 | GDSC1000 | pan-cancer | AAC | -0.085 | 0.009 |
| mRNA | SB-743921 | CTRPv2 | pan-cancer | AAC | -0.087 | 0.01 |